Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » IsoPlexis Raises Additional $20M as Part of Series C Round

IsoPlexis Raises Additional $20M as Part of Series C Round

Jan 09, 2020
|
staff reporter

NEW YORK – IsoPlexis said today that it has raised an additional $20 million as part of its Series C financing.

That follows the $25 million the company announced in May 2019, bringing the total figure for the round to $45 million. The round was led by Northpond Ventures, along with participation from existing investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

What's Popular?

In Business News

  1. DiaSorin to Acquire Luminex for $1.8B

  2. 10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit

  3. Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

  4. Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

  5. People in the News: New Appointments at Mission Bio, Akoya Biosciences, Micronoma, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.